Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 260.00
Ask: 270.00
Change: 0.00 (0.00%)
Spread: 10.00 (3.846%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 265.00
ANP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

17 Mar 2021 07:01

RNS Number : 4998S
Anpario PLC
17 March 2021
 

Anpario plc

("Anpario" or the "Group")

 

Directorate change

 

Anpario, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity is pleased to announce the appointment of Marc Wilson as Group Finance Director with effect from 1 July 2021.

 

Following Karen Prior's request to relinquish the role of Group Finance Director a succession planning exercise was undertaken during 2020. The Nomination Committee unanimously approved the selection of Marc Wilson as Group Finance Director and recommended his appointment to the Board with effect from 1 July 2021. Karen will remain as an Executive Director of the Group responsible for Corporate Social Responsibility and as Company Secretary.

 

Marc has been part of Anpario's multi-faceted internal development programme and has worked closely with Karen and the Board on matters of strategic finance for the Group in recent years.

 

Marc is a member of the Chartered Institute of Management Accountants and currently Group Management Accountant as part of the Executive Management team for Anpario. Marc joined Anpario in 2010 and his responsibilities have included the development and rollout of Anpario's global ERP system and the accounting and integration of acquisitions during this time. He is currently Director of several UK and International subsidiaries of the Group.

 

Peter Lawrence, Chairman, stated:

 

"We are pleased to announce this further change to the Board which concludes a series of recent announcements forming part of a Board succession plan. Karen has been a dedicated and professional colleague since joining the Board in 2009 and will continue to work closely with Marc to ensure a smooth transition of his role. We welcome Marc to the Board and Karen's new role gives further strength to the Executive team and our focus on ESG matters."

 

The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies:

 

Marc Charles Wilson (formerly Garner), aged 33, holds or has held the following directorships or partnerships in the past five years:

Current directorships/appointments

Agil Limited

Director

Anpario (Thailand) Ltd.

Director

Anpario Pty Ltd

Director

Anpario UK Limited

Director

Aquatice Limited

Director

Kiotech Limited

Director

Kiotechagil Limited

Director

Meriden Animal Health Limited

Director

Optivite International Limited

Director

Optivite Limited

Director

Orego-Stim Limited

Director

 

Past directorships/appointments

None

 

Marc Wilson currently holds 9,676 existing ordinary shares in Anpario, representing approximately 0.04% of the issued share capital of the Company. Marc also has options for a further 20,000 ordinary shares under the Joint Share Ownership Plan (the "JSOP" scheme) and 5,577 ordinary shares under The Anpario SAYE Share Option Scheme 2013.

 

There is no further information required to be disclosed under Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

Anpario plc

Richard Edwards, CEO

+44(0) 777 6417 129

Karen Prior, Group Finance Director

+44(0) 1909 537380

Peel Hunt LLP (NOMAD)

+44 (0)20 7418 8900

Adrian Trimmings

Andrew Clark

Will Bell

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAFDXFDDFEEA
Date   Source Headline
21st Mar 202411:37 amRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSAward of Options and Director/PDMR Shareholding
24th Jan 20247:00 amRNSFull year trading statement
17th Jan 20247:00 amRNSBlock listing Interim Review
5th Oct 20239:23 amRNSDirector Disclosure
13th Sep 20237:00 amRNSHalf-year Report
25th Aug 20235:10 pmRNSBlock listing Interim Review
1st Aug 20237:00 amRNSDirectorate Change
10th Jul 20232:14 pmRNSHolding(s) in Company
7th Jul 20232:34 pmRNSHolding(s) in Company
29th Jun 20233:57 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
23rd Jun 20237:00 amRNSResult of Tender Offer
19th Jun 20232:48 pmRNSGM Statement
15th Jun 20237:00 amRNSShareholder Tour
7th Jun 20234:09 pmRNSReplacement - Tender Offer
6th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20237:00 amRNSTender Offer
23rd May 20237:00 amRNSChange of Adviser
19th May 20234:40 pmRNSDirector Disclosures
19th May 20233:35 pmRNSTotal Voting Rights
5th May 20237:00 amRNSDirectorate Change
21st Apr 20237:00 amRNSAnpario receives King’s Award for Enterprise
11th Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20231:13 pmRNSHolding(s) in Company
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSFinal Results
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
24th Jan 202312:56 pmRNSBlock listing Interim Review
9th Jan 20237:00 amRNSFull Year Trading Statement
16th Dec 20227:00 amRNSAnpario receives ISO 14001 Certification
4th Nov 202212:52 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSDirector/PDMR Shareholding - Replacement
18th Oct 20227:00 amRNSDirector/PDMR Shareholding
6th Oct 20227:00 amRNSESG Initiatives
3rd Oct 20222:32 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSHalf-year Report
5th Sep 202212:38 pmRNSTotal Voting Rights
5th Aug 20222:00 pmRNSBob The Pigeon Back Home in Gateshead, Pet!
20th Jul 20221:02 pmRNSBlock listing Interim Review
7th Jul 20222:59 pmRNSHolding(s) in Company
22nd Jun 202211:24 amRNSAGM Statement
16th Jun 20226:00 pmRNSResult of AGM
16th Jun 20227:00 amRNSAGM Statement
27th May 202212:56 pmRNSHolding(s) in Company
24th May 20221:10 pmRNSHolding(s) in Company
11th May 20227:00 amRNSNotice of AGM
10th May 20223:55 pmRNSHolding(s) in Company
5th May 20223:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.